Science Explorer Interactive view Map
Company · Hong Kong · China

Sino Biopharmaceutical (China)

sinobiopharm.comROR OpenAlex
Research works
66
▲ 1139% vs 2013–17
Citations
531
8.0 per fractional work
Top-10% rate
14.5%
record average 16.5%
Open access
35%
world 28%

Not ranked overall: Sino Biopharmaceutical (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.06× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.78× its world share, 9 worksBiochemistry, Geneti…Immunology and Microbiology: 12.53× its world share, 6 worksImmunology and Micro…Neuroscience: 0.74× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.14× its world share, 0 worksPharmacology, Toxico…Chemistry: 2.33× its world share, 2 worksChemistryComputer Science: 0.19× its world share, 1 worksComputer ScienceEnergy: 0.16× its world share, 0 worksEnergyEngineering: 0.20× its world share, 1 worksEngineeringEnvironmental Science: 0.13× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.34× its world share, 1 worksMaterials ScienceMedicine: 2.54× its world share, 23 worksMedicineNursing: 0.95× its world share, 0 worksNursingVeterinary: 1.32× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.03× its world share, 0 worksBusiness, Management…Decision Sciences: 0.11× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.21× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 12.5×. Every wedge is a field page.

Which keywords describe research at Sino Biopharmaceutical (China)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Immunotherapy, Glycosylation, Cancer, Fc Receptors, Therapeutic Antibodies, Immunotherapy, Cancer Therapy and Immunity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Immunotherapy6▲ 90×3 topics
  2. Glycosylation6▲ 119×3 topics
  3. Cancer5▲ 7.3×16 topics
  4. Inflammation4▲ 4.3×23 topics
  5. Fc Receptors4▲ 160×1 topic
  6. Therapeutic Antibodies4▲ 126×1 topic
  7. Immunotherapy4▲ 12×5 topics
  8. Cancer Therapy4▲ 14×11 topics
  9. Immunity3▲ 18×5 topics
  10. Tumor Regression3▲ 63×2 topics
  11. Innate Immunity3▲ 18×3 topics
  12. Lymphoma3▲ 36×2 topics
  13. Antigen Presentation2▲ 56×2 topics
  14. CAR T Cells2▲ 67×1 topic
  15. Chimeric Antigen Receptor2▲ 67×1 topic
  16. Dendritic Cells2▲ 54×1 topic
  17. Tumor Antigen2▲ 78×1 topic
  18. Gene Therapy2▲ 23×4 topics
  19. BRCA Mutation2▲ 191×1 topic
  20. Cell Death2▲ 19×2 topics
  21. Immune Regulation2▲ 38×2 topics
  22. Immune System2▲ 18×3 topics
  23. Macrophages2▲ 24×2 topics
  24. PARP Inhibitors2▲ 191×1 topic
  25. Tumor Microenvironment2▲ 9.8×4 topics
  26. CD472▲ 224×1 topic
  27. Therapeutics2▲ 38×2 topics
  28. apoptotic cells2▲ 224×1 topic
  29. Breast Cancer2▲ 15×3 topics
  30. Glycans2▲ 113×1 topic
  31. Mucins2▲ 113×1 topic
  32. Chemotherapy2▲ 4.8×5 topics
  33. Metabolism2▲ 6.8×6 topics
  34. Tumor Targeting2▲ 20×3 topics
  35. PET Imaging2▲ 19×3 topics
  36. Immune Checkpoint Blockade1▲ 26×1 topic
  37. Monoclonal Antibody1▲ 59×2 topics
  38. PD-1 and PD-L11▲ 26×1 topic
  39. Vaccine1▲ 7.5×4 topics
  40. Targeted Therapy1▲ 11×4 topics

Which research topics does Sino Biopharmaceutical (China) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses, CAR-T cell therapy research and PARP inhibition in cancer therapy.

Monoclonal and Polyclona…4Monoclonal and Polyclonal Antibodies Research: 4 fractional worksImmunotherapy and Immune Responses: 2 fractional worksCAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksPARP inhibition in cance…2PARP inhibition in cancer therapy: 2 fractional worksPhagocytosis and Immune Regulation: 2 fractional worksGlycosylation and Glycoproteins Research: 2 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksHER2/EGFR in Cancer Research: 1 fractional worksRadiopharmaceutical Chemistry and Applications: 1 fractional worksCancer Research and Treatments: 1 fractional works
Radiology, Nuclear Medicine and ImagingImmunologyOncologyMolecular Biology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 4 works
  2. 2 Immunotherapy and Immune Responses Immunology 2 works
  3. 3 CAR-T cell therapy research Oncology 2 works
  4. 4 PARP inhibition in cancer therapy Oncology 2 works
  5. 5 Phagocytosis and Immune Regulation Immunology 2 works
  6. 6 Glycosylation and Glycoproteins Research Molecular Biology 2 works
  7. 7 Cancer Immunotherapy and Biomarkers Oncology 1 works
  8. 8 HER2/EGFR in Cancer Research Oncology 1 works
  9. 9 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
  10. 10 Cancer Research and Treatments Biotechnology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.3%not open64.7%

World: 28% of research is openly available.

with international co-authors18.3%domestic only81.7%

World: 19% is written across borders.

How has Sino Biopharmaceutical (China)'s research output changed?

Output in 2018–2022 was 1139% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Hong Kong

All research institutions in Hong Kong

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.